Saskia Middeldorp Selected Research

mRNA Vaccines

1/2022	Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
11/2021	Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saskia Middeldorp Research Topics

Disease

63	Hemorrhage 03/2024 - 05/2008
62	Venous Thromboembolism 03/2024 - 03/2002
33	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024 - 07/2003
32	Thrombosis (Thrombus) 03/2024 - 07/2003
25	Pulmonary Embolism 09/2022 - 01/2004
23	Thrombophilia 11/2023 - 01/2004
21	Neoplasms (Cancer) 11/2023 - 05/2008
19	COVID-19 04/2024 - 11/2020
14	Thrombocytopenia (Thrombopenia) 03/2024 - 07/2017
12	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023 - 01/2009
11	Pregnancy Complications 02/2022 - 08/2008
9	Atrial Fibrillation 05/2024 - 10/2014
9	Habitual Abortion (Recurrent Miscarriage) 01/2023 - 01/2009
8	Pre-Eclampsia (Preeclampsia) 01/2020 - 07/2014
7	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2024 - 01/2021
7	Thromboembolism 10/2022 - 03/2005
6	Spontaneous Abortion (Miscarriage) 01/2023 - 01/2009
6	Critical Illness (Critically Ill) 10/2022 - 07/2021
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2006
4	Stroke (Strokes) 05/2024 - 12/2020
4	Protein S Deficiency (Deficiency, Protein S) 11/2023 - 03/2005
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 01/2019
4	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 07/2014
4	Uterine Hemorrhage (Uterine Bleeding) 01/2019 - 10/2015
4	Obesity 01/2016 - 01/2005
4	Hyperhomocysteinemia 07/2008 - 10/2004
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2016
3	Pulmonary Hypertension 09/2022 - 01/2019
3	Inflammation (Inflammations) 01/2022 - 11/2014
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 08/2018
3	Hypersensitivity (Allergy) 03/2021 - 01/2015
3	Menorrhagia 02/2021 - 10/2015
3	Myocardial Infarction 12/2020 - 09/2004
3	Overweight 01/2016 - 09/2007
2	Hematoma 05/2024 - 01/2022
2	Ischemic Stroke 05/2024 - 12/2017
2	Cerebral Hemorrhage 05/2024 - 01/2022
2	Postthrombotic Syndrome 07/2022 - 11/2018
2	Frailty 01/2022 - 10/2018

Drug/Important Bio-Agent (IBA)

59	AnticoagulantsIBA 03/2024 - 03/2002
29	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2024 - 05/2008
26	Heparin (Liquaemin)FDA LinkGeneric 03/2024 - 05/2008
26	Vitamin K FDA Link 01/2024 - 12/2004
15	RivaroxabanIBA 01/2023 - 10/2015
15	Prothrombin (Factor II)IBA 03/2021 - 07/2003
14	Factor Xa InhibitorsIBA 05/2024 - 10/2013
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2021 - 01/2009
12	factor V LeidenIBA 01/2020 - 03/2002
11	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023 - 01/2009
10	Protein CIBA 11/2023 - 07/2008
10	edoxabanIBA 01/2023 - 10/2013
8	Hemostatics (Antihemorrhagics)IBA 05/2024 - 01/2005
8	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2024 - 12/2013
8	AntithrombinsIBA 11/2023 - 09/2007
8	fibrin fragment D (D-dimer)IBA 11/2021 - 01/2017
8	Oral ContraceptivesIBA 01/2019 - 01/2005
8	Factor VIII (Coagulation Factor VIII)IBA 10/2010 - 10/2002
7	PRT064445IBA 05/2024 - 01/2016
7	VaccinesIBA 03/2024 - 08/2021
7	apixabanIBA 01/2023 - 11/2016
7	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 10/2013
7	Protein SIBA 11/2011 - 03/2005
6	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
6	Fondaparinux (Arixtra)FDA Link 12/2018 - 05/2008
5	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2016
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 02/2012
4	AntibodiesIBA 01/2023 - 09/2017
4	Estrogens (Estrogen)FDA Link 01/2023 - 01/2005
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 01/2011
4	Ad26COVS1IBA 01/2022 - 01/2021
4	COVID-19 VaccinesIBA 01/2022 - 01/2021
4	Thrombin FDA Link 01/2022 - 06/2014
4	ORALIT (ORS)IBA 12/2021 - 10/2017
4	Dabigatran FDA Link 03/2021 - 10/2014
3	AntidotesIBA 01/2023 - 01/2021
3	Antiphospholipid AntibodiesIBA 01/2023 - 09/2017
3	Contraceptive Agents (Contraceptives)IBA 01/2023 - 05/2014
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2022 - 10/2013
3	Hemoglobins (Hemoglobin)IBA 12/2021 - 10/2015
3	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 08/2018
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 01/2016
3	A-factor (Streptomyces)IBA 01/2019 - 08/2011
3	Hormones (Hormone)IBA 01/2019 - 01/2009
3	vinyltriethoxysilane (VTES)IBA 12/2018 - 02/2014
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 06/2014 - 10/2002
2	EnzymesIBA 03/2024 - 05/2015
2	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 01/2020
2	Cytochrome P-450 CYP3AIBA 01/2022 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2021
2	mRNA VaccinesIBA 01/2022 - 11/2021

Therapy/Procedure

41	Therapeutics 05/2024 - 12/2004
5	Duration of Therapy 11/2018 - 08/2012
3	Drug Therapy (Chemotherapy) 12/2021 - 12/2014
3	Compression Stockings 11/2018 - 09/2016
2	Catheters 01/2024 - 07/2017
2	Contraindications 01/2024 - 04/2013
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2023 - 11/2011
2	Anticoagulation Reversal 06/2022 - 01/2021
2	Polypharmacy 01/2022 - 01/2022